MedPath
TGA Approval

BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial (292528)

292528

BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial

Pfizer Australia Pty Ltd

October 19, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/60003775561b4feb51b1e883ff75abdb.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/2ebd0c6de4bb3f8f513849a1c45d04e7.pdf

Active Ingredients

bupivacaine hydrochloride monohydrate

adrenaline (epinephrine) acid tartrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial (292528) - TGA 批准文号 | MedPath